Commit To Buy Fate Therapeutics At $10, Earn 17.1% Annualized Using Options
September 19, 2018 at 11:54 AM EDT
Investors considering a purchase of Fate Therapeutics Inc (FATE) shares, but tentative about paying the going market price of $13.57/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2019 put at the $10 strike, which has a bid at the time of this writing of 70 cents..